Search

Your search keyword '"Corrado L"' showing total 1,250 results

Search Constraints

Start Over You searched for: Author "Corrado L" Remove constraint Author: "Corrado L"
1,250 results on '"Corrado L"'

Search Results

1. Risk Characterization of Botanical Extracts Containing Hydroxyanthracenes as Determined by a Validated Micronucleus In Vitro Assay

2. Lack of genotoxicity of rhubarb (rhizome) in the Ames and micronucleus in vitro tests

3. Lack of in vivo genotoxic effect of dried whole Aloe ferox juice

4. US regulations to curb alleged cancer causes are ineffectual and compromised by scientific, constitutional and ethical violations

5. Prevalence and predictive role of hypertriglyceridemia in statin-treated patients at very high risk: Insights from the START study

6. SCCS Scientific Opinion on Acid Yellow 3 (submission II) – SCCS/1631/21

7. SCCS scientific opinion on Butylated hydroxytoluene (BHT) - SCCS/1636/21

9. The SCCS Notes of Guidance for the testing of cosmetic ingredients and their safety evaluation, 11th revision, 30–31 March 2021, SCCS/1628/21

10. The EU chemicals strategy for sustainability: in support of the BfR position

15. US regulations to curb alleged cancer causes are ineffectual and compromised by scientific, constitutional and ethical violations

16. Prevalence and predictive role of hypertriglyceridemia in statin-treated patients at very high risk: insights from the START Study

18. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (Nature Genetics, (2021), 53, 12, (1636-1648), 10.1038/s41588-021-00973-1)

19. Upholding science in health, safety and environmental risk assessments and regulations

20. Scientific Opinion on Acid Yellow 3 (submission II) - SCCS/1631/21

23. SCCS scientific opinion on Butylated hydroxytoluene (BHT) - SCCS/1636/21″

26. An Investigation of the Role of Common and Rare Variants in a Large Italian Multiplex Family of Multiple Sclerosis Patients

27. Metal(loid)s role in the pathogenesis of amyotrophic lateral sclerosis: Environmental, epidemiological, and genetic data

28. COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: Insights from the STARTregistry

29. The EU chemicals strategy for sustainability: in support of the BfR position

31. Association of Variants in the SPTLC1 Gene with Juvenile Amyotrophic Lateral Sclerosis

34. SCCS Scientific Opinion on Acid Yellow 3 (submission II) – SCCS/1631/21

35. Lack of in vivo genotoxic effect of dried whole Aloe ferox juice

36. GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

38. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

39. Characterization of the p.L145F and p.S135N Mutations in SOD1: Impact on the Metabolism of Fibroblasts Derived from Amyotrophic Lateral Sclerosis Patients

40. Characterization of the p.L145F and p.S135N Mutations in SOD1: Impact on the Metabolism of Fibroblasts Derived from Amyotrophic Lateral Sclerosis Patients

42. Six months of different exercise type in sedentary primary schoolchildren: impact on physical fitness and saliva microbiota composition

43. Antithrombotic therapy in idiopathic infertility

44. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (vol 53, pg 1636, 2021)

45. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (Nature Genetics, (2021), 53, 12, (1636-1648), 10.1038/s41588-021-00973-1)

47. COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: Insights from the STARTregistry

49. Lung (extracorporeal CO2 removal) and renal (continuous renal replacement therapy) support: the role of ultraprotective strategy in Covid 19 and non-Covid 19 ARDS. A case-control study

Catalog

Books, media, physical & digital resources